10.38USD-6.65%Mkt Cap: 282.18M $P/E: —1d ago
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spin…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Avg
1M Perf
Higher
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap282.18M $
Enterprise Value202.42M $
Revenue (TTM)56.44M $
Gross Profit38.04M $
Net Income (TTM)-29.63M $
Revenue/Share2.842 USD
Last Price10.38 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees127
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.23
PEG—
EV/EBITDA-5.99
EV/Revenue3.59
P/S5.00
P/B3.06
EPS (TTM)-0.98
EPS (Forward)-1.44
52W Range
8.50022% of range17.19
52W High17.19 USD
52W Low8.500 USD
Profitability
Gross Margin75.31%
Oper. Margin-57.56%
EBITDA Margin-59.87%
Profit Margin-58.67%
ROE-29.97%
ROA-22.77%
Growth
Revenue Growth58.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.98M $
CapEx (TTM)1.36M $
FCF Margin-46.78%
FCF Yield-9.36%
Net Debt-79.76M $
Net Debt/EBITDA2.36
Balance Sheet
Debt/Equity0.18
Current Ratio11.88
Quick Ratio11.25
Book Value/Sh3.394 USD
Cash/Share3.569 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)18.40 USD
Upside (mean)+77.3%
Target Range16.00 USD – 23.00 USD
$16.00+77.3% to mean$23.00
# Analysts5
Ownership
Shares Out.27.18M
Float15.55M
Insiders43.73%
Institutions39.73%
Short Interest
Short Ratio6.5d
Short % Float12.97%
Short % Out.4.82%
Shares Short1.31M
Short (prev mo.)649.33K
Technical
SMA 5010.64 (-2.5%)
SMA 20012.15 (-14.6%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)170.11K
Avg Vol (10d)156.78K
Technical Indicators
RSI (14)45.2
MACD0.0080
MACD Signal0.0210
MACD Hist.-0.0129
BB Upper12.01 USD
BB Middle10.87 USD
BB Lower9.731 USD
BB Width20.94%
ATR (14)0.7685 USD
Vol Ratio (20d)0.75x